1-14 of 14
Robert Zeillinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3041: Duplex Sequencing detects cancer-associated mutations arising during normal aging: Clonal evolution over a century of human lifetime

Jesse J. Salk, Elisabeth Maritschnegg, Paul Speiser, Robert Zeillinger, Rosana Risques, Lawrence A. Loeb
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3041.
https://doi.org/10.1158/1538-7445.AM2017-3041
Published: 01 July 2017
View article titled, Abstract 3041: Duplex Sequencing detects cancer-associated mutations arising during normal aging: Clonal evolution over a century of human lifetime
Journal Articles

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Bernard Leroy, Mandy L. Ballinger, Fanny Baran-Marszak, Gareth L. Bond, Antony Braithwaite, Nicole Concin, Lawrence A. Donehower, Wafik S. El-Deiry, Pierre Fenaux, Gianluca Gaidano, Anita Langerød, Eva Hellstrom-Lindberg, Richard Iggo, Jacqueline Lehmann-Che, Phuong L. Mai, David Malkin, Ute M. Moll, Jeffrey N. Myers, Kim E. Nichols, Sarka Pospisilova, Patricia Ashton-Prolla, Davide Rossi, Sharon A. Savage, Louise C. Strong, Patricia N. Tonin, Robert Zeillinger, Thorsten Zenz, Joseph F. Fraumeni, Jr, Peter E.M. Taschner, Pierre Hainaut, Thierry Soussi
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (6): 1250–1260.
https://doi.org/10.1158/0008-5472.CAN-16-2179
Published: 14 March 2017
View article titled, Recommended Guidelines for Validation, Quality Control, and Reporting of <em>TP53</em> Variants in Clinical Practice
Open the PDF for Recommended Guidelines for Validation, Quality Control, and Reporting of <em>TP53</em> Variants in Clinical Practice in another window
Includes: Supplementary data
Journal Articles

Abstract LB-197: Circulating rare cells enable highly efficient cancer detection

Eva Obermayr, Elisabeth Maritschnegg, Paul Speiser, Christian Singer, Eva M. Schuster, Sabine Danzinger, Nina Pecha, Robert Zeillinger
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): LB-197.
https://doi.org/10.1158/1538-7445.AM2015-LB-197
Published: 01 August 2015
View article titled, Abstract LB-197: Circulating rare cells enable highly efficient cancer detection
Journal Articles

Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer

Sandra Bondong, Thomas Hielscher, Alain Zeimet, Robert Zeillinger, Isabelle Cadron, Jalid Sehouli, Ignace Vergote, Sven Mahner, Paul Speiser, Ioana Braicu, Monica Huszar, Mina Fogel, Peter Altevogt
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4723.
https://doi.org/10.1158/1538-7445.AM2011-4723
Published: 15 April 2011
View article titled, Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer
Journal Articles

OATP-uptake transporters in ovarian cancer cells: implications for the uptake of drugs and estrogens

Martin Svoboda, Katrin Wlcek, Veronika Auner, Dan Tong, Robert Zeillinger, Walter Jaeger, Theresia Thalhammer
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3252.
Published: 01 May 2008
View article titled, OATP-uptake transporters in ovarian cancer cells: implications for the uptake of drugs and estrogens
Journal Articles

HCRP1 contributes to degradation of activated EGFR, a mechanism highly relevant for ovarian cancer

Michael Wittinger, Dietmar Pils, Ahmed El-Gazzar, Robert Zeillinger, Thomas Grunt, Michael Krainer
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3427.
Published: 01 May 2008
View article titled, HCRP1 contributes to degradation of activated EGFR, a mechanism highly relevant for ovarian cancer
Journal Articles

Tumor suppressor BARD1: a biomarker of cancer and target for treatment

Lin Li, Stephan Ryser, Eva Dizin, Robert Zeillinger, Irmgard Irminger-Finger
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2183.
Published: 01 May 2008
View article titled, Tumor suppressor BARD1: a biomarker of cancer and target for treatment
Journal Articles

Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers

Lin Li, Stephan Ryser, Eva Dizin, Dietmar Pils, Michael Krainer, Charles Edward Jefford, Francesco Bertoni, Robert Zeillinger, Irmgard Irminger-Finger
Journal: Cancer Research
Cancer Res (2007) 67 (24): 11876–11885.
https://doi.org/10.1158/0008-5472.CAN-07-2370
Published: 18 December 2007
View article titled, Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers
Open the PDF for Oncogenic BARD1 Isoforms Expressed in Gynecological Cancers in another window
Includes: Supplementary data
Journal Articles

Whole genome screening for epigenetically silenced genes using a panel of epithelial cancer cell lines

Dietmar Pils, Brigitte Wolf, Michael Wittinger, Jochen Reibenwein, Bernd Mayer, Dominique Koensgen, Alexander Mustea, Isabelle Cadron, Toon van Gorp, Sven Mahner, Nicole Concin, Dan Cacsire-Castillo Tong, Robert Zeillinger, Michael Krainer
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 251.
Published: 01 May 2007
View article titled, Whole genome screening for epigenetically silenced genes using a panel of epithelial cancer cell lines
Journal Articles

Hypermethylation of N33 (TUSC3) as independent molecular predictor for ovarian cancer

Dietmar Pils, Peter Horak, Andreas Kirisits, Andreas Gleiss, Markus Omann, Alexander Pinter, Christoph Zielinski, Alexander Mustea, Dominique Koensgen, Robert Zeillinger, Michael Krainer
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 760.
Published: 15 April 2006
View article titled, Hypermethylation of <em>N33</em> (<em>TUSC3</em>) as independent molecular predictor for ovarian cancer
Journal Articles

TRAIL receptor 1 (DR4) is frequently methylated in ovarian cancer: Relevance for TRAIL sensitivity and ovarian cancer tumorigenesis

Peter Horak, Dietmar Pils, Griet Haller, Reinhard Horvath, Sandra Tomek, Robert Zeillinger, Christoph Zielinski, Michael Krainer
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 586–587.
Published: 01 May 2005
View article titled, TRAIL receptor 1 (DR4) is frequently methylated in ovarian cancer: Relevance for TRAIL sensitivity and ovarian cancer tumorigenesis
Journal Articles

Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo

Nicole Concin, Kirsten Becker, Neda Slade, Susan Erster, Elizabeth Mueller-Holzner, Hanno Ulmer, Guenter Daxenbichler, Alain Zeimet, Robert Zeillinger, Christian Marth, Ute M. Moll
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2449–2460.
https://doi.org/10.1158/0008-5472.CAN-03-1060
Published: 01 April 2004
View article titled, Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors <em>in Vivo</em>
Open the PDF for Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors <em>in Vivo</em> in another window
Journal Articles

An Interleukin-6 Gene Promoter Polymorphism Influences the Biological Phenotype of Ovarian Cancer

Lukas A. Hefler, Christoph Grimm, Sven Ackermann, Sabine Malur, Amir R. Radjabi-Rahat, Sepp Leodolter, Matthias W. Beckmann, Robert Zeillinger, Heinz Koelbl, Clemens B. Tempfer
Journal: Cancer Research
Cancer Res (2003) 63 (12): 3066–3068.
Published: 15 June 2003
View article titled, An Interleukin-6 Gene Promoter Polymorphism Influences the Biological Phenotype of Ovarian Cancer
Open the PDF for An Interleukin-6 Gene Promoter Polymorphism Influences the Biological Phenotype of Ovarian Cancer in another window
Journal Articles

Mapping of DNA Amplifications at 15 Chromosomal Localizations in 1875 Breast Tumors: Definition of Phenotypic Groups

Frank Courjal, Marguerite Cuny, Joelle Simony-Lafontaine, Geneviève Louason, Paul Speiser, Robert Zeillinger, Carmen Rodriguez, Charles Theillet
Journal: Cancer Research
Cancer Res (1997) 57 (19): 4360–4367.
Published: 01 October 1997
View article titled, Mapping of DNA Amplifications at 15 Chromosomal Localizations in 1875 Breast Tumors: Definition of Phenotypic Groups
Open the PDF for Mapping of DNA Amplifications at 15 Chromosomal Localizations in 1875 Breast Tumors: Definition of Phenotypic Groups in another window